The Centers for Disease Control and Prevention (CDC) in the United States reported 21 cases of the Oropouche virus in travelers returning from Cuba as of August 16. According to a weekly report released on August 27 by this health entity, 20 of the cases were detected in Florida and one was diagnosed in New York.
Most of the cases "had fever and other symptoms that resolved without specific treatment." However, the source added that at least three individuals experienced a recurrence of symptoms after appearing to be cured, a common characteristic noted by the Ministry of Public Health (MINSAP) itself.
The CDC reported that it is collaborating with state public health jurisdictions and international partners to enable rapid detection and surveillance of the virus transmission to guide public health prevention measures.
Just over a week ago, the CDC had already issued a level 2 alert, on a scale of 4, due to the rising cases of the Oropouche virus in Cuba. On its website, the CDC warned, "Multiple cases of Oropouche have been reported in American and European travelers returning from trips to Cuba, indicating an ongoing risk."
U.S. authorities recommended that travelers take reinforced preventive measures to avoid contracting this arboviral disease, while pregnant women were advised not to travel to the island unless absolutely necessary.
The alert came at a time when Cuba is facing an epidemiological crisis, exacerbated by the rapid spread of the disease across the country, following the confirmation of the first cases in Santiago de Cuba at the end of May.
In addition to the Oropouche virus cases imported to the United States, the number of cases imported to Europe has been increasing in recent weeks through travelers mainly from Cuba. At least twenty cases have already been detected, according to data from the European Centre for Disease Prevention and Control (ECDC).
The Oropouche virus, often confused with dengue due to the similarity of symptoms, can occur in people of any age. Symptoms include high fever, headache, muscle pain, joint stiffness, nausea, vomiting, chills, and light sensitivity.
It is important for those developing the disease to avoid taking aspirin and other non-steroidal anti-inflammatory drugs, such as ibuprofen, to reduce the risk of bleeding.
The Pan American Health Organization (PAHO) issued an epidemiological alert in early August, highlighting the severity of the situation in the Americas.
There have been reported fatalities due to Oropouche, with the first cases recorded globally at the end of July in Brazil.
Key Information About the Oropouche Virus
Here are some frequently asked questions and answers regarding the Oropouche virus, its symptoms, and preventive measures.
What are the symptoms of the Oropouche virus?
Symptoms of the Oropouche virus include high fever, headache, muscle pain, joint stiffness, nausea, vomiting, chills, and light sensitivity.
How is the Oropouche virus transmitted?
The Oropouche virus is primarily transmitted through the bite of infected midges, which are small flying insects.
What preventive measures should travelers take?
Travelers should take reinforced preventive measures such as using insect repellent, wearing long-sleeved clothing, and avoiding areas with high insect activity. Pregnant women are advised to avoid travel to high-risk areas.
Are there any treatments for the Oropouche virus?
There is no specific treatment for the Oropouche virus. Symptoms are usually managed with supportive care, and patients are advised to avoid taking aspirin and other non-steroidal anti-inflammatory drugs to reduce the risk of bleeding.